Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Drug

United Laboratories Receives FDA Approval for Clinical Study of UBT251 for Obesity Treatment

November 18, 2024
CompanyDrug

BioTroy Therapeutics Receives US FDA IND Approval for Anti-Tumor Drug BT02

November 18, 2024
CompanyDrug

Sichuan Kelun-Biotech’s KL-A167 and SKB264 Gain Tacit Clinical Trial Approval in China

November 18, 2024
Company

Sino Biopharmaceutical Reports H1 2023 Revenue Growth, Focus on Innovative Drugs

November 18, 2024
CompanyDeals

Suzhou Novoprotein and Shanghai Model Organisms Center Ink Global Partnership

November 18, 2024
Company

Sihuan Pharmaceutical Reports H1 2023 Revenue Dip Amid R&D Focus

November 18, 2024
CompanyMedical Device

CIRC Unveils FuZhi 1.0 Smart Nuclear Medicine System at Chinese Medical Association Meeting

December 27, 2024
Policy / Regulatory

Hunchun Port Designated as Medical Materials Import Port by NMPA and GAC

November 18, 2024
Company

Baxter Appoints Wu Xin as China General Manager Amid Spin-Off of Kidney Care Business

November 18, 2024
Company

China Grand Pharmaceutical Reports H1 2023 Revenues and Pipeline Progress

November 18, 2024
CompanyDrug

EC Approves AbbVie’s Tepkinly for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

November 19, 2024
CompanyDrug

Sanofi’s Altuviiio Receives Marketing Approval from Japan’s MHLW for Hemophilia A Treatment

November 19, 2024
1 2 3 4 5 … 24 25
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up